Jenburkt Pharmaceuticals is currently trading at Rs. 451.95, up by 2.95 points or 0.66% from its previous closing of Rs. 449.00 on the BSE.
The scrip opened at Rs. 452.90 and has touched a high and low of Rs. 452.90 and Rs. 446.05 respectively. So far 2586 shares were traded on the counter.
The BSE group 'XC' stock of face value Rs. 10 has touched a 52 week high of Rs. 572.50 on 04-Nov-2016 and a 52 week low of Rs. 340.10 on 18-Aug-2016.
Last one week high and low of the scrip stood at Rs. 458.80 and Rs. 442.30 respectively. The current market cap of the company is Rs. 209.22 crore.
The promoters holding in the company stood at 45.81%, while Institutions and Non-Institutions held 0.48% and 53.71% respectively.
Jenburkt Pharmaceuticals has achieved a milestone of crossing Rs 100 crore in sales (gross and unaudited) as on March 21, 2017.
Jenburkt Pharmaceuticals is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products.